Nitric oxide and response to inhaled bradykinin in severe asthma.
Black
P N
PN
Brodie
S M
SM
D000280:Administration, Inhalation; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000503:physiopathology*; D001920:Bradykinin / Q000494:pharmacology*; D001985:Bronchial Provocation Tests; D016022:Case-Control Studies; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D019323:omega-N-Methylarginine / Q000494:pharmacology
D018927:Anti-Asthmatic Agents; D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D001920:Bradykinin